{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:30:05Z","timestamp":1778963405566,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,1,14]],"date-time":"2017-01-14T00:00:00Z","timestamp":1484352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI089672"],"award-info":[{"award-number":["U19AI089672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.ijpddr.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,3,11]],"date-time":"2017-03-11T11:31:07Z","timestamp":1489231867000},"page":"131-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Interactions between tafenoquine and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum"],"prefix":"10.1016","volume":"7","author":[{"given":"Karen","family":"Kemirembe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mynthia","family":"Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2017.03.002_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/1475-2875-9-275","article-title":"Pharmacokinetics of artemether and dihydroartemisinin in healthy Pakistani male volunteers treated with artemether-lumefantrine","volume":"9","author":"Ali","year":"2010","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1128\/CMR.00008-09","article-title":"Resistance to therapies for infection by Plasmodium vivax","volume":"22","author":"Baird","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib3","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/424663","article-title":"Primaquine therapy for malaria","volume":"39","author":"Baird","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib4","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.160.3833.1233","article-title":"Primaquine-induced changes in morphology of exoerythrocytic stages of malaria","volume":"160","author":"Beaudoin","year":"1968","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2017.03.002_bib5","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.femsle.2005.09.035","article-title":"Antimalarial drug synergism and antagonism: mechanistic and clinical significance","volume":"253","author":"Bell","year":"2005","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib6","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1128\/AAC.06248-11","article-title":"Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study","volume":"56","author":"Benjamin","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/infdis\/137.2.122","article-title":"A\u00a0method for testing for synergy with any number of agents","volume":"137","author":"Berenbaum","year":"1978","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib8","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.bcp.2005.07.021","article-title":"Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum","volume":"70","author":"Bray","year":"2005","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib9","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/AAC.42.5.1293","article-title":"Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial","volume":"42","author":"Brueckner","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"issue":"Pt 4","key":"10.1016\/j.ijpddr.2017.03.002_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1017\/S0031182099003960","article-title":"Chloroquine increases Plasmodium falciparum gametocytogenesis in\u00a0vitro","volume":"118","author":"Buckling","year":"1999","journal-title":"Parasitology"},{"key":"10.1016\/j.ijpddr.2017.03.002_bib11","doi-asserted-by":"crossref","first-page":"7650","DOI":"10.1128\/AAC.01948-15","article-title":"In\u00a0vitro activities of primaquine-schizonticide combinations on asexual blood stages and gametocytes of Plasmodium falciparum","volume":"59","author":"Cabrera","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib12","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1128\/AAC.00790-10","article-title":"Tafenoquine, an antiplasmodial 8-aminoquinoline, targets leishmania respiratory complex III and induces apoptosis","volume":"54","author":"Carvalho","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib13","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1128\/AAC.00879-15","article-title":"The oral antimalarial drug tafenoquine shows activity against Trypanosoma brucei","volume":"59","author":"Carvalho","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543784.16.5.705","article-title":"Tafenoquine: a promising new antimalarial agent","volume":"16","author":"Crockett","year":"2007","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ijpddr.2017.03.002_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1475-2875-12-408","article-title":"Identification of inhibitors of Plasmodium falciparum gametocyte development","volume":"12","author":"Duffy","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/nrmicro2239","article-title":"Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria","volume":"7","author":"Eastman","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib17","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.trstmh.2006.04.003","article-title":"Gender differences in gastrointestinal disturbances and plasma concentrations of tafenoquine in healthy volunteers after tafenoquine administration for post-exposure vivax malaria prophylaxis","volume":"101","author":"Edstein","year":"2007","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/1475-2875-12-332","article-title":"Cytostatic versus cytocidal profiling of quinoline drug combinations via modified fixed-ratio isobologram analysis","volume":"12","author":"Gorka","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib19","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1128\/AAC.01588-16","article-title":"Pharmacokinetic interactions between tafenoquine and dihydroartemisinin-piperaquine or artemether-lumefantrine in healthy adult subjects","volume":"60","author":"Green","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib20","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1002\/jcph.302","article-title":"Tafenoquine at therapeutic concentrations does not prolong Fridericia-corrected QT interval in healthy subjects","volume":"54","author":"Green","year":"2014","journal-title":"J.\u00a0Clin. Pharmacol."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib21","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/AAC.42.3.682","article-title":"Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in\u00a0vitro","volume":"42","author":"Hawley","year":"1998","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2307\/3280287","article-title":"Synchronization of Plasmodium falciparum erythrocytic stages in culture","volume":"65","author":"Lambros","year":"1979","journal-title":"J.\u00a0Parasitol."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/BF00928413","article-title":"Effect of the 8-aminoquinoline primaquine on culture-derived gametocytes of the malaria parasite Plasmodium falciparum","volume":"77","author":"Lanners","year":"1991","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1475-2875-13-141","article-title":"Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections","volume":"13","author":"Li","year":"2014","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib25","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(13)62568-4","article-title":"Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study","volume":"383","author":"Llanos-Cuentas","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2017.03.002_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.exppara.2013.09.010","article-title":"Plasmodium falciparum: generation of pure gametocyte culture by heparin treatment","volume":"135","author":"Miao","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib27","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1475-2875-10-263","article-title":"Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration","volume":"10","author":"Morris","year":"2011","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib28","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1128\/AAC.01656-08","article-title":"Role of known molecular markers of resistance in the antimalarial potency of piperaquine and dihydroartemisinin in\u00a0vitro","volume":"53","author":"Muangnoicharoen","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib29","doi-asserted-by":"crossref","first-page":"620","DOI":"10.4269\/ajtmh.2008.79.620","article-title":"Pharmacokinetics of the antimalarial drug piperaquine in healthy Vietnamese subjects","volume":"79","author":"Nguyen","year":"2008","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1128\/EC.00267-08","article-title":"Apicoplast and mitochondrion in gametocytogenesis of Plasmodium falciparum","volume":"8","author":"Okamoto","year":"2009","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.ijpddr.2017.03.002_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1475-2875-11-34","article-title":"Anti-malarial drugs: how effective are they against Plasmodium falciparum gametocytes?","volume":"11","author":"Peatey","year":"2012","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/inthealth\/ihv017","article-title":"Artemisinin-based combination therapy in the treatment of uncomplicated malaria: review of recent regulatory experience at the European Medicines Agency","volume":"7","author":"Pelfrene","year":"2015","journal-title":"Int. Health"},{"key":"10.1016\/j.ijpddr.2017.03.002_bib33","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4269\/ajtmh.1999.60.1019","article-title":"Risk factors for gametocyte carriage in uncomplicated falciparum malaria","volume":"60","author":"Price","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib34","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1016\/S0140-6736(96)91488-9","article-title":"Effects of artemisinin derivatives on malaria transmissibility","volume":"347","author":"Price","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2017.03.002_bib35","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S1473-3099(14)70855-2","article-title":"Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis","volume":"14","author":"Price","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4269\/ajtmh.2002.67.39","article-title":"In\u00a0vitro activity of tafenoquine alone and in combination with artemisinin against Plasmodium falciparum","volume":"67","author":"Ramharter","year":"2002","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib37","doi-asserted-by":"crossref","first-page":"17486","DOI":"10.1073\/pnas.1310402110","article-title":"Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in\u00a0vivo assessment of hemolytic toxicity","volume":"110","author":"Rochford","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib38","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s12936-015-0815-z","article-title":"Improvement of culture conditions for long-term in\u00a0vitro culture of Plasmodium vivax","volume":"14","author":"Roobsoong","year":"2015","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/321866","article-title":"Malaria chemoprophylaxis in the age of drug resistance. II. Drugs that may be available in the future","volume":"33","author":"Shanks","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib40","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","article-title":"Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening","volume":"48","author":"Smilkstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1473-3099(10)70187-0","article-title":"Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial","volume":"10","author":"Smithuis","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.pt.2004.05.004","article-title":"The co-existence of Plasmodium: sidelights from falciparum and vivax malaria in Thailand","volume":"20","author":"Snounou","year":"2004","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12936-016-1145-5","article-title":"Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial","volume":"15","author":"St Jean","year":"2016","journal-title":"Malar. J."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib44","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/1947601912440575","article-title":"Quantitative methods for assessing drug synergism","volume":"2","author":"Tallarida","year":"2011","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ijpddr.2017.03.002_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.parint.2006.12.005","article-title":"Short-term in\u00a0vitro culture of field isolates of Plasmodium vivax using umbilical cord blood","volume":"56","author":"Udomsangpetch","year":"2007","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib46","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1128\/AAC.43.3.598","article-title":"8-Aminoquinolines active against blood stage Plasmodium falciparum in\u00a0vitro inhibit hematin polymerization","volume":"43","author":"Vennerstrom","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib47","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1128\/AAC.00343-15","article-title":"Differential cytochrome P450 2D metabolism alters tafenoquine pharmacokinetics","volume":"59","author":"Vuong","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2017.03.002_bib48","doi-asserted-by":"crossref","first-page":"e93825","DOI":"10.1371\/journal.pone.0093825","article-title":"A\u00a0flow cytometry-based quantitative drug sensitivity assay for all Plasmodium falciparum gametocyte stages","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2017.03.002_bib49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1473-3099(12)70198-6","article-title":"Primaquine to prevent transmission of falciparum malaria","volume":"13","author":"White","year":"2013","journal-title":"Lancet Infect. Dis."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320717300052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320717300052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:46:34Z","timestamp":1761921994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320717300052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S2211320717300052"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2017.03.002","relation":{},"ISSN":["2211-3207"],"issn-type":[{"value":"2211-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions between tafenoquine and artemisinin-combination therapy partner drug in asexual and sexual stage Plasmodium falciparum","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}